The typical subtypes include breast cancers that express oestrogen receptor (ER) and/or progesterone receptor (PR), those expressing HER2, or triple negative breast cancer (TNBC), characterised by the absence of these receptors [23,24]. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.